Bharat Biotech asked to provide more data on COVID-19 vaccine Covaxin for below 12-year-olds

Apr 22, 2022

New Delhi [India], April 22 : The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for...

DCGI expert panel asks SII, Bharat Biotech to provide more safety, efficacy data for COVID-19 vaccines

Dec 09, 2020

New Delhi[India], December 9 : In a major development related to COVID-19 vaccine, Subject Expert Committee (SEC) of Drugs Controller General of India (DCGI)...

SEC asks for more data to grant full market approval to Covaxin and Covishield

Jan 14, 2022

New Delhi [India], January 14 : The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) will continue thorough review of data submitted...

Expecting 'one' additional information on Covaxin, decision on emergency use listing after complete assessment: WHO

Oct 18, 2021

Geneva [Switzerland], October 18 : World Health Organisation (WHO), which is reviewing the data provided by Bharat Biotech for Emergency Use Listing of COVID-19...

COVID-19 vaccination for children: CDSCO approved ZyCoV-D for restricted use in emergency situations

Nov 30, 2021

New Delhi [India], November 30 : The Interim Phase II, III clinical trial data of COVAXIN on Healthy Volunteers aged 2 to 18 years...

Bharat Biotech shares full data of all research studies of Covaxin

Jun 12, 2021

New Delhi [India], June 12 : Bharat Biotech on Saturday shared full data of all research studies of its Covaxin-- India's first indigenous COVID-19...